Exponent (NASDAQ:EXPO – Get Free Report) announced its quarterly earnings results on Thursday. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.13, Briefing.com reports. Exponent had a net margin of 18.69% and a return on equity of 28.49%. The company had revenue of $137.21 million for the quarter, compared to analysts’ expectations of $125.98 million. During the same quarter in the previous year, the company earned $0.56 earnings per share. Exponent’s quarterly revenue was up 6.6% on a year-over-year basis.
Exponent Price Performance
Exponent stock traded up $18.66 during midday trading on Friday, reaching $98.34. 552,166 shares of the company traded hands, compared to its average volume of 306,798. The firm has a market capitalization of $4.98 billion, a price-to-earnings ratio of 49.94 and a beta of 0.68. The business has a 50 day moving average of $79.55 and a two-hundred day moving average of $81.92. Exponent has a 12 month low of $64.61 and a 12 month high of $102.72.
Exponent Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, March 8th were paid a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.14%. The ex-dividend date was Thursday, March 7th. This is an increase from Exponent’s previous quarterly dividend of $0.26. Exponent’s dividend payout ratio is currently 57.44%.
Insider Activity at Exponent
Analyst Upgrades and Downgrades
EXPO has been the topic of a number of recent research reports. Truist Financial cut their price objective on shares of Exponent from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Friday, February 2nd. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a report on Monday, March 4th.
Get Our Latest Research Report on EXPO
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Stocks Leading the U.S. Agriculture Comeback
- Upcoming IPO Stock Lockup Period, Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
- What Makes a Stock a Good Dividend Stock?
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.